Allgrove syndrome (AS) or 3A syndrome (AAA) is characterized by a triad of adrenocorticotrophic hormone (ACTH) resistant adrenal insufficiency, alacrimia, and achalasia along with progressive neurological impairment with or without mild mental retardation. This activity outlines the evaluation and management of Allgrove syndrome and highlights the role of the healthcare team in improving care for patients with this condition.

**Objectives:**
- Identify the etiology of Allgrove syndrome.
- Review the process for the evaluation of Allgrove syndrome.
- Summarize the management options available for Allgrove syndrome
- Discuss interprofessional team strategies for improving care coordination and communication to advance Allgrove syndrome and improve outcomes.